Your reliable supplier of generic medications.
product caduet is not found!
Sorry we do not carry caduet at this time.
- You can try to search caduet in our product database - CLICK HERE TO SEARCH.
- Fill in the product request form and we will add the requested medicine shortly - PRODUCT REQUEST FORM
Just wanted to write and say that I'm VERY satisfied with my purchase. I was skeptical at first, the price seemed too good and the shipping process too convoluted. But I sucked it up and took the plunge, ordered 90 of the lil blue guys and sat back to wait for packages that might never come. Happily I was SO wrong! 9 days after my order was placed I received my first batch of 30+4, and just today (another week later) I received the remaining 60. The quality of the product is outstanding. If you\'re sitting there, wondering whether or not you should go ahead and make a purchase here, quit wondering! The best prices, excellent service, and a top-notch product are all present here. Go for it!
Our billing is certified by:
- Ranbaxy Labs - Q1CY12 Result update/ Estimate change - Centrum - Equity Bulls
Ranbaxy Labs - Q1CY12 Result update/ Estimate change - CentrumEquity BullsRLL reported 71%YoY growth in revenues due to FTF opportunities of generic Lipitor and Caduet in the US market.
- Lipitor delivers impressive margins for Ranbaxy - Hindu Business Line
Business TodayLipitor delivers impressive margins for RanbaxyHindu Business LineRanbaxy Laboratories' sales growth and high profit margins were helped mainly by sales of Lipitor and Caduet on an exclusive basis in the US.
- Ranbaxy's Net Profit Soars - Wall Street Journal
Wall Street JournalRanbaxy's Net Profit SoarsWall Street JournalThe introduction of the much-awaited Lipitor generic in November, followed by authorized sales of a generic version of Pfizer's Caduet blood-pressure pill, contributed in a big way to Ranbaxy's sales and earnings.
- Buy Ranbaxy Laboratories; target Rs 559: Emkay - Moneycontrol.com
Moneycontrol.
- Ranbaxy: Positives priced in - Business Standard (blog)
Business LineRanbaxy: Positives priced inBusiness Standard (blog)Sales in the US surged a huge 159 per cent to $410 million in the March quarter, of which Lipitor (a cholesterol lowering drug) and Caduet (a drug prescribed to treat conditions that affect the heart and blood vessels) contributed around $316 million.
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
